Lina Steinrud Mørch

ORCID: 0000-0001-6506-2569 · 13 papers in corpus
observational 2026
PLoS medicine ·doi:10.1371/journal.pmed.1004652

BACKGROUND: Sex hormones have been implicated in leukemogenesis, but evidence regarding hormonal contraceptive use and leukemia risk remains limited and primarily based on older formulations. Given the widespread use of contemporary hormona…

observational 2026
Pharmacoepidemiology and drug safety ·doi:10.1002/pds.70436

PURPOSE: While having a chronic medical disease (CMD) increases use of analgesics and anti-inflammatory drugs, sufficient knowledge regarding patterns of use during pregnancy is lacking. We aimed to describe ibuprofen use before and in earl…

other 2025
JAMA ·doi:10.1001/jama.2024.28778
observational 2025
American journal of ophthalmology ·doi:10.1016/j.ajo.2025.05.027

PURPOSE: To investigate the association between hormonal contraceptive use and the risk of retinal vascular occlusions in women of reproductive age. DESIGN: Register-based, nationwide cohort study. PARTICIPANTS: A total of 2,208,172 women…

observational 2025
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2024-082801

OBJECTIVE: To evaluate the association between contemporary hormonal contraceptive use and the risk of incident ischaemic stroke and myocardial infarction. DESIGN: Real-world, nationwide, prospective cohort study. SETTING: Denmark, by use…

observational 2024
BMJ medicine ·doi:10.1136/bmjmed-2023-000753

OBJECTIVE: To estimate the rate of breast cancer associated with use of vaginal oestradiol tablets according to duration and intensity of their use. DESIGN: Registry based, case-control study, nested in a nationwide cohort. SETTING: Based…

other 2024
JAMA ·doi:10.1001/jama.2024.18575
observational 2024
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2023.100813

BACKGROUND: Use of the high-dose levonorgestrel-releasing intrauterine system (LNG-IUS) has been associated with increased risk of incident depression. Evidence is lacking on the influence of use of two recently marketed low-dose LNG-IUS on…

other 2023
JAMA ·doi:10.1001/jama.2023.0380
observational 2023
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2022-074450

OBJECTIVE: To study the influence of concomitant use of hormonal contraception and non-steroidal anti-inflammatory drugs (NSAIDs) on the risk of venous thromboembolism. DESIGN: Nationwide cohort study. SETTING: Denmark through national re…

observational 2021
EClinicalMedicine ·doi:10.1016/j.eclinm.2021.100882

BACKGROUND: Oral tranexamic acid is effective for heavy menstrual bleeding, but the thrombosis risk with this treatment is largely not studied. METHODS: Using nationwide registries, we assessed associations between use of oral tranexamic a…

observational 2018
BMJ (Clinical research ed.) ·doi:10.1136/bmj.k3609

OBJECTIVES: To investigate the association between contemporary combined hormonal contraceptives (including progestogen types in combined preparations and all progestogen-only products) and overall and specific types of ovarian cancer. DES…

observational 2018
PloS one ·doi:10.1371/journal.pone.0206358

IMPORTANCE: The association between the use of hormonal contraceptive and pancreatic cancer among premenopausal women has until now been unclear. This is the first study to investigate the risk of pancreatic cancer in pre-menopausal women. …